Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients ...

Patients with history of preeclampsia have increased risk for myocardial infarction and worse myocardial infarction outcomes.

A new study published in the Journal of American Medical Association found that in patients with myocardial infarction (MI) ...

After suffering from acute myocardial infarction, the mortality rate of local health insurance subscribers was higher than that of working subscribers. A joint research team led by Professor Kang ...

Liberal blood transfusion after heart attack in patients with kidney disease (CKD) is not harmful, according to study results.

Oxygen has been used in the treatment of myocardial infarction (MI) and acute coronary syndromes for over 100 years.1 The rationale for its longstanding use is that it increases oxygen delivery to the ...

Acute MI mortality has fallen, yet deaths from other diseases, including heart failure and hypertension, are on the rise.

The sudden death of Shefali Jariwala has highlighted a concerning trend. Heart attacks are increasingly affecting younger ...

A new meta-analysis published in the Journal of American Medical Association found an early invasive strategy did not reduce ...

A new study highlights a sharp decline in deaths from heart attacks, while showing a significant rise in mortality from other ...

For patients with T2D, semaglutide seems to confer some advantage over empagliflozin in terms of mortality and CV event risks.

Hormonal influences, microvascular function, and psychosocial factors all interplay in ways that uniquely affect women’s ...